To evaluate the efficacy and safety of apremilast in treating oral ulcers (OUs), the cardinal and high-disabling feature of Behçet's disease (BD).
Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience
De Luca, Giacomo;Campochiaro, Corrado;Tomelleri, Alessandro;Cavalli, Giulio;Dagna, Lorenzo
2019-01-01
Abstract
To evaluate the efficacy and safety of apremilast in treating oral ulcers (OUs), the cardinal and high-disabling feature of Behçet's disease (BD).File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
